SCHEMBL4553950

SCHEMBL4553950

CNNC(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formamide SCHEMBL28160645 0.87 GAA (0.36)
SCHEMBL605889 0.83 GAA (0.48)
SCHEMBL19088258 0.77
SCHEMBL19088344 0.77
SCHEMBL1528231 0.75 GAA (0.39)
SCHEMBL103435 0.73
SCHEMBL11926269 0.73 GAA (0.41)
SCHEMBL7561299 0.73 GAA (0.41)
SCHEMBL18076628 0.73 GAA (0.46)
SCHEMBL6778465 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230346951-A1 MOLECULAR DEGRADERS OF EXTRACELLULAR PROTEINS YALE UNIVERSITY 2023-11-02 US disclosed
US-20220162225-A1 PH-DEPENDENT COMPOSITION MATTERS USEFUL FOR STUDY AND DIAGNOSIS OF ALZHEIMER'S DISEASE PURDUE RESEARCH FOUNDATION (US) 2022-05-26 US disclosed
US-11092594-B2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use VENTANA MEDICAL SYSTEMS, INC. (US) 2021-08-17 US disclosed
EP-3313884-B9 ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOF IMMUNOGEN INC (US) 2021-05-19 EP disclosed
US-20200407781-A1 METHOD FOR TRANSPOSASE-MEDIATED SPATIAL TAGGING AND ANALYZING GENOMIC DNA IN A BIOLOGICAL SAMPLE 10X GENOMICS, INC. 2020-12-31 US disclosed
US-10815248-B2 Labeled chemically reactive and biologically active conjugates, and methods and compositions thereof SUN YI (US) 2020-10-27 US disclosed
US-20200277663-A1 METHODS FOR DETERMINING A LOCATION OF A BIOLOGICAL ANALYTE IN A BIOLOGICAL SAMPLE 10X GENOMICS, INC. 2020-09-03 US disclosed
EP-3409498-B1 LITHOGRAPHIC PRINTING ORIGINAL PLATE FOR ON-PRESS DEVELOPMENT, METHOD FOR PRODUCING LITHOGRAPHIC PRINTING PLATE AND LITHOGRAPHIC PRINTING METHOD FUJIFILM CORP (JP) 2020-03-18 EP disclosed
US-20180120306-A1 HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE VENTANA MED SYST INC (US) 2018-05-03 US disclosed
US-9850318-B2 Antibodies to quetiapine haptens and use thereof JANSSEN PHARMACEUTICA NV (BE) 2017-12-26 US disclosed
US-20140213766-A1 HAPTENS OF OLANZIPINE ORTHO-CLINICAL DIAGNOSTICS, INC. (US) 2014-07-31 US disclosed
US-20140057303-A1 Antibodies to Olanzapine Haptens and Use Thereof JANSSEN PHARMACEUTICA NV (BE) 2014-02-27 US disclosed
US-20130072492-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS MERCK SHARP & DOHME LLC 2013-03-21 US disclosed
US-20120108585-A1 BENZOXAZOLES, BENZTHIAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20110319411-A1 ISOINDOLINONE AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRTIS PHARMACEUTICALS, INC. (US) 2011-12-29 US disclosed
WO-2011149921-A1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS MERCK SHARP & DOHME CORP. (US) 2011-12-01 WO disclosed
US-20110124637-A1 BENZIMIDAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2011-05-26 US disclosed
US-7713701-B2 DNA-binding polymers CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2010-05-11 US disclosed
US-20090155202-A1 DNA-BINDING POLYMERS CALIFORNIA INSTITUTE OF TECHNOLOGY 2009-06-18 US disclosed
US-7452730-B2 DNA-binding polymers CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2008-11-18 US disclosed